Steven R. Vigna

Steven R. Vigna

Auto-generated profile, based on publicly available information

Steven R. Vigna

Departments of Cell Biology and Medicine, Duke University Medical Center, Durham, NC 27710, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Pancreas
Verified
Journal Article
Closed access
SVSteven R. Vigna
Steven R. Vigna
RSRafiq A. Shahid
Rafiq A. Shahid
JNJaimie D. Nathan
Jaimie D. Nathan
DMDouglas C. McVey
Douglas C. McVey
RLRodger A. Liddle
Rodger A. Liddle
Objectives: We tested the hypothesis that leukotriene B4 (LTB4) mediates pancreatic inflammation in rats via activation of the transient receptor potential vanilloid 1 (TRPV1). Methods: Leukotriene B4 or a vehicle was administered to adult rats via celiac axis injection after pretreatment with the TRPV1 antagonist, capsazepine, or vehicle, and the severity of subsequent pancreatitis was assessed by measuring pancreatic edema, myeloperoxidase (MPO) activity, and histological grading. In a second experiment, acute pancreatitis was induced by common pancreaticobiliary duct ligation. Six hours after surgery, pancreatic tissue levels of LTB4 were determined by enzyme-linked immunosorbent assay. Also, the effects of inhibition of LTB4 biosynthesis by pretreatment with the 5-lipoxygenase-activating peptide inhibitor, MK-886, were determined. Results: Celiac axis administration of LTB4 significantly increased pancreatic edema and MPO activity, and produced histological evidence of pancreatic edema, neutrophil infiltration, and necrosis. Capsazepine pretreatment significantly reduced all inflammatory parameters in LTB4-induced pancreatitis. Pancreatic tissue levels of LTB4 were significantly elevated in rats that underwent common pancreaticobiliary duct ligation compared with control rats. MK-886 pretreatment significantly inhibited pancreatic edema, histological damage, and pancreatic MPO concentrations. Conclusions: Common pancreaticobiliary duct obstruction causes an increase in pancreatic LTB4 concentrations that in turn mediates activation of TRPV1 resulting in acute pancreatitis.

1 January 1993 in Neuropeptides
Verified
Journal Article
Closed access
WKW.R. Kilgore
W.R. Kilgore
PMP.W. Mantyh
P.W. Mantyh
CMC.R. Mantyh
C.R. Mantyh
DMD.C. McVey
D.C. McVey
SVS.R. Vigna
S.R. Vigna

1 May 2005 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
DMDouglas C. McVey
Douglas C. McVey
SVSteven R. Vigna
Steven R. Vigna

31 January 1993 in Journal of Surgical Research
Verified
Journal Article
Closed access
MFMarwan Farouk
Marwan Farouk
SVSteven R. Vigna
Steven R. Vigna
JHJon E. Haebig
Jon E. Haebig
TGTom W. Gettys
Tom W. Gettys
DMDouglas C. McVey
Douglas C. McVey
WMWilliam C. Meyers
William C. Meyers

1 January 2017 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
SVSteven R. Vigna
Steven R. Vigna
Clostridium difficiletoxin A is a colonic inflammatory agent that acts partially by activation of TRPV1 (transient receptor potential vanilloid type 1). Resiniferatoxin (RTX) is an excitotoxin that activates TRPV1 at low concentrations and defunctionalizes TRPV1 at high concentrations. RTX at various doses was injected intraluminally into isolated ileal segments in anesthetized rats. After 3 hours, the treated segments were removed and inflammation was assessed. This acute treatment with RTX resulted in biphasic responses: (1) an increase in inflammation similar to that caused by toxin A and capsaicin at low doses of up to 100 ng RTX and (2) no inflammatory effect of RTX at higher doses (1–100 μg), consistent with a defunctionalizing or neurotoxic effect of RTX at high doses. Separately, anesthetized rats were treated with RTX enemas and one or four weeks later were challenged with toxin A. Toxin A-induced colitis was significantly inhibited one week after an RTX enema, and this effect was RTX dose dependent. When tested four weeks after administration of the RTX enema, protection against toxin A colitis was lost. In conclusion, an RTX enema protects against toxin A-induced colitis in rats for at least one week but less than four weeks.

1 January 2014 in International Journal of Inflammation
Verified
Journal Article
Open access
PDF file
SVSteven R. Vigna
Steven R. Vigna
We tested the hypothesis that 5-aminosalicylic acid (5-ASA) inhibits toxin A-induced generation of colonic leukotriene B4(LTB4) and toxin A colitis in rats. Isolated colonic segments in anesthetized rats were treated intraluminally with toxin A for 3 hours with or without 30 minutes of pretreatment with either 5-ASA or sulfapyridine and then colonic tissue levels of LTB4were measured and inflammation was assessed. Separately, sulfasalazine was administered to rats in their drinking water for 5 days, isolated colonic segments were then prepared, toxin A was administered, and inflammation was assessed as before. Pretreatment with 5-ASA inhibited toxin A-induced increased tissue LTB4concentration in the colon. Sulfasalazine and 5-ASA but not sulfapyridine significantly inhibited toxin A colitis. However, pretreatment with 5-ASA did not protect against direct TRPV1-mediated colitis caused by capsaicin. Toxin A stimulated the release of substance P (SP), and this effect was also inhibited by sulfasalazine and 5-ASA but not by sulfapyridine. Thus, toxin A stimulates colonic LTB4resulting in activation of TRPV1, release of SP, and colitis. Inhibition of 5-LO by 5-ASA disrupts this pathway and supports the concept that LTB4activation of TRPV1 plays a role in toxin A colitis.